JP2011530277A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530277A5
JP2011530277A5 JP2011521593A JP2011521593A JP2011530277A5 JP 2011530277 A5 JP2011530277 A5 JP 2011530277A5 JP 2011521593 A JP2011521593 A JP 2011521593A JP 2011521593 A JP2011521593 A JP 2011521593A JP 2011530277 A5 JP2011530277 A5 JP 2011530277A5
Authority
JP
Japan
Prior art keywords
acid sequence
amino acid
epstein
seq
barr virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011521593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011530277A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/060277 external-priority patent/WO2010015705A1/en
Publication of JP2011530277A publication Critical patent/JP2011530277A/ja
Publication of JP2011530277A5 publication Critical patent/JP2011530277A5/ja
Pending legal-status Critical Current

Links

JP2011521593A 2008-08-08 2009-08-07 Ebv(エプスタイン−バーウイルス)潜在性膜タンパク質(lmp1)の細胞内領域に結合する抗体を含んでなる医薬組成物 Pending JP2011530277A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08162083.3 2008-08-08
EP08162083 2008-08-08
PCT/EP2009/060277 WO2010015705A1 (en) 2008-08-08 2009-08-07 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of ebv (epstein-barr virus) latent membrane protein-1 (lmp1)

Publications (2)

Publication Number Publication Date
JP2011530277A JP2011530277A (ja) 2011-12-22
JP2011530277A5 true JP2011530277A5 (enExample) 2012-09-06

Family

ID=40210594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521593A Pending JP2011530277A (ja) 2008-08-08 2009-08-07 Ebv(エプスタイン−バーウイルス)潜在性膜タンパク質(lmp1)の細胞内領域に結合する抗体を含んでなる医薬組成物

Country Status (5)

Country Link
US (1) US20120107319A1 (enExample)
EP (1) EP2331572A1 (enExample)
JP (1) JP2011530277A (enExample)
CN (1) CN102177177A (enExample)
WO (1) WO2010015705A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012072516A1 (en) 2010-11-29 2012-06-07 Centre National De La Recherche Scientifique (Cnrs) Barf1 a diagnostic and prognostic marker for epstein-barr virus (ebv)-associated lymphoma
CN103145849B (zh) * 2013-02-18 2014-06-11 冯振卿 嵌合抗原受体及其用途
CA3031725A1 (en) * 2016-08-02 2018-02-08 Baochun Zhang Lmp1-expressing cells and methods of use thereof
CN111647564B (zh) * 2020-05-18 2023-07-04 李欣 抗eb病毒lmp1的单克隆抗体及其细胞株和应用
AU2022422147A1 (en) 2021-12-23 2024-07-04 Sana Biotechnology, Inc. Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229043A1 (en) * 2001-01-30 2002-08-07 Cyto-Barr B.V. Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith
US7786269B2 (en) * 2001-12-04 2010-08-31 Dana-Farber Cancer Institute, Inc. Antibody to latent membrane proteins and uses thereof

Similar Documents

Publication Publication Date Title
JP2012115277A5 (enExample)
JP2011528896A5 (enExample)
JP2011528895A5 (enExample)
JP2012082206A5 (enExample)
JP2012126742A5 (enExample)
JP2012095652A5 (enExample)
JP2008536483A5 (enExample)
JP2010519931A5 (enExample)
JP2013027391A5 (enExample)
JP2013048638A5 (enExample)
JP2010166916A5 (enExample)
JP2011528897A5 (enExample)
JP2008530245A5 (enExample)
JP2018520997A5 (enExample)
JP2008529558A5 (enExample)
JP2014529399A5 (enExample)
JP2009213477A5 (enExample)
JP2014501510A5 (enExample)
JP2008525033A5 (enExample)
JP2011530277A5 (enExample)
JP2008538183A5 (enExample)
JP2010519252A5 (enExample)
JP2012532601A5 (enExample)
JP2010535026A5 (enExample)
JP2010508030A5 (enExample)